- Home
- CTSO vs PXLW Comparison
CTSO vs PXLW Comparison
Compare CTSO & PXLW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTSO
- PXLW
- Stock Information
- Founded
- CTSO 1997
- PXLW 1997
- Country
- CTSO United States
- PXLW United States
- Employees
- CTSO N/A
- PXLW N/A
- Industry
- CTSO Medical/Dental Instruments
- PXLW Semiconductors
- Sector
- CTSO Health Care
- PXLW Technology
- Exchange
- CTSO Nasdaq
- PXLW Nasdaq
- Market Cap
- CTSO 48.2M
- PXLW 41.8M
- IPO Year
- CTSO N/A
- PXLW 2000
- Fundamental
- Price
- CTSO $0.86
- PXLW $0.73
- Analyst Decision
- CTSO Strong Buy
- PXLW Strong Buy
- Analyst Count
- CTSO 3
- PXLW 3
- Target Price
- CTSO $4.67
- PXLW $2.17
- AVG Volume (30 Days)
- CTSO 135.6K
- PXLW 294.1K
- Earning Date
- CTSO 11-07-2024
- PXLW 02-06-2025
- Dividend Yield
- CTSO N/A
- PXLW N/A
- EPS Growth
- CTSO N/A
- PXLW N/A
- EPS
- CTSO N/A
- PXLW N/A
- Revenue
- CTSO $37,739,531.00
- PXLW $54,190,000.00
- Revenue This Year
- CTSO $8.08
- PXLW N/A
- Revenue Next Year
- CTSO $12.80
- PXLW $18.92
- P/E Ratio
- CTSO N/A
- PXLW N/A
- Revenue Growth
- CTSO 1.80
- PXLW N/A
- 52 Week Low
- CTSO $0.70
- PXLW $0.61
- 52 Week High
- CTSO $1.97
- PXLW $3.08
- Technical
- Relative Strength Index (RSI)
- CTSO 42.77
- PXLW 48.37
- Support Level
- CTSO $0.80
- PXLW $0.72
- Resistance Level
- CTSO $1.09
- PXLW $0.86
- Average True Range (ATR)
- CTSO 0.08
- PXLW 0.04
- MACD
- CTSO -0.00
- PXLW -0.01
- Stochastic Oscillator
- CTSO 13.19
- PXLW 30.50
About CTSO Cytosorbents Corporation
CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales, Distributors/strategic partners, and Government segments. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.
About PXLW Pixelworks Inc.
Pixelworks Inc is a provider of visual processing semiconductor and software solutions that enable consistently high-quality and authentic viewing experiences in a wide variety of applications. The company defines its key target markets as Mobile (smartphone and tablet), Home and Enterprise (projectors, personal video recorders (PVR), and over-the-air (OTA) streaming devices), and Cinema (creation, remastering, and delivery of digital video content). The company operates in one segment: the design, development, marketing and sale of IC solutions for use in electronic display devices. The company generates its revenue from two broad product markets: the Mobile market and the Home and Enterprise market. The majority of the revenue is earned in China.